Related Experiment Video
Updated: Mar 2, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Emergency Physician Patterns Related to Anticoagulation of Patients with Recent-Onset Atrial Fibrillation and Flutter
Paraish Misra1, Eddy Lang1, Catherine M Clement2
1Division of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada.
Insights
Emergency departments rarely initiate anticoagulation for patients with recent-onset atrial fibrillation and flutter (RAFF) and high embolic risk (CHADS₂ score ≥ 2). This practice gap requires further investigation and potential educational interventions to improve patient care.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Long-term anticoagulation with warfarin is recommended for patients with newly recognized atrial fibrillation (AF) and high embolic risk (CHADS₂ score ≥ 2).
- Patterns of emergency department (ED)-initiated anticoagulation for recent-onset atrial fibrillation and flutter (RAFF) in Canada are not well-defined.
- Understanding factors influencing anticoagulation decisions in the ED is crucial for guideline adherence.
Purpose of the Study:
- To determine patterns of ED-initiated anticoagulation among eligible Canadian patients with RAFF.
- To assess whether anticoagulation decisions are primarily driven by the CHADS₂ score or other clinical factors.
- To identify predictors of anticoagulation initiation in the ED setting for RAFF patients.
Main Methods:
- Retrospective analysis of health records from 8 Canadian university EDs over 12 months.
- Inclusion criteria: RAFF requiring emergency management, no prior warfarin use, not admitted to hospital.
- Statistical analyses included univariate tests (T-test, Chi-square) and multiple logistic regression.
Main Results:
- Only 18% of eligible patients (120) with a CHADS₂ score ≥ 2 received anticoagulation.
- Among patients receiving anticoagulation (70), only 30% had a CHADS₂ score ≥ 2.
- Independent predictors of anticoagulation included older age, concurrent heparin use, new metoprolol prescription, and cardiology referral. A CHADS₂ score ≥ 2 was associated but not an independent predictor.
Conclusions:
- Patients discharged from the ED with RAFF were not prescribed anticoagulation in accordance with current guidelines.
- A significant practice gap exists in ED-initiated anticoagulation for high-risk RAFF patients.
- Educational initiatives or enhanced ED support may be needed to improve anticoagulation prescribing for RAFF.
Abstract:
Guidelines strongly recommend long-term anticoagulation with warfarin for patients with newly recognized AF who have high embolic risk by virtue of a CHADS2 (Congestive Heart Failure, Hypertension, Age >65, Diabetes, History of Stroke) score ≥ 2. The goal of this study was to determine patterns of emergency department-initiated anticoagulation among eligible patients discharged from Canadian centers with an episode of recent-onset atrial fibrillation and flutter (RAFF) and determine if decision-making is driven by the CHADS2 score or other factors. This was accomplished by examining health records using uniform case identification and data abstraction as well as centralized quality control; it was conducted in 8 Canadian university emergency departments over a 12-month period. Eligible patients for this analysis demonstrated RAFF requiring emergency management, were not already taking warfarin and were not admitted to hospital. Univariate analyses were conducted using T-test or Chi-square to select factors associated with anticoagulation initiation at a significance level of p < 0.15 and multiple logistic regression was employed to evaluate independent predictors after adjustment for confounders. Among 633 eligible patients, only 21 out of 120 patients (18%) with a CHADS2 score ≥ 2 received anticoagulation and among 70 patients who were given anticoagulation only 21 (30%) had a CHADS2 score ≥ 2. Independent predictors of anticoagulation included age by 10-year strata: (OR = 1.7; 95% CI 1.3 - 2.1), heparin use in the anticoagulation (OR = 9.6; 95% CI 4.9 - 18.9), a new prescription for metoprolol (OR = 9.6; 95% CI 4.9 - 18.9) and being referred to cardiology for follow-up (OR = 5.6; 95% CI 2.6 - 12.0). CHADS2 ≥ 2 doubled the likelihood of being prescribed anticoagulation (OR= 2.0; 95% CI 1.5 - 3.5) but was not an independent predictor. It was thus determined that patients discharged from the emergency department in this study were not prescribed anticoagulation in keeping with current recommendations. This practice gap merits further investigation and may benefit from educational efforts or enhanced support for anticoagulation use from the emergency department.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Venous Thrombosis III: Interprofessional Care
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Dysrhythmias V: Evaluating Dysrhythmias
Venous Thrombosis IV: Nursing Management

